| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003741463 |
| P356 | DOI | 10.1007/S10689-009-9233-0 |
| P8608 | Fatcat ID | release_f5cg4y25vzdgzjfhj2v6rkl7ka |
| P698 | PubMed publication ID | 19165625 |
| P2093 | author name string | Henry T Lynch | |
| Poonam Sharma | |||
| Stephen N Thibodeau | |||
| Kristen M Drescher | |||
| Zoran Gatalica | |||
| Patrice Watson | |||
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Cancer statistics, 2004 | Q29620739 | ||
| Genetic susceptibility to non-polyposis colorectal cancer | Q33764029 | ||
| Effector memory T cells, early metastasis, and survival in colorectal cancer | Q33992461 | ||
| Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege | Q33997713 | ||
| Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity | Q34505678 | ||
| Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells | Q35169601 | ||
| E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells | Q35228257 | ||
| Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer | Q35354010 | ||
| In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer | Q35574242 | ||
| Histopathological identification of colon cancer with microsatellite instability | Q35746344 | ||
| High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability | Q35787046 | ||
| HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences | Q35875965 | ||
| Role of the pathologist in the diagnosis of hereditary non-polyposis colorectal cancer | Q35940616 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion | Q36641756 | ||
| Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. | Q36671108 | ||
| New aspects in molecular diagnosis of Lynch syndrome (HNPCC). | Q36693766 | ||
| Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease | Q38306073 | ||
| Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer | Q38463997 | ||
| Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers | Q39994336 | ||
| Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites. | Q40073121 | ||
| Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression | Q40142911 | ||
| Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells | Q40156868 | ||
| Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta | Q40168787 | ||
| Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis | Q40352971 | ||
| Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma | Q40436418 | ||
| The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. | Q40483110 | ||
| Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens | Q40801080 | ||
| Natural history of hereditary cancer of the breast and colon | Q41457494 | ||
| Prolonged survival as a component of a hereditary breast and nonpolyposis colon cancer | Q41638893 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma | Q43653063 | ||
| Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. | Q43708532 | ||
| Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. | Q43782950 | ||
| Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. | Q43792267 | ||
| Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. | Q44274945 | ||
| The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. | Q48032094 | ||
| Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia | Q48257624 | ||
| Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. | Q50893078 | ||
| Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. | Q51994331 | ||
| Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. | Q53353136 | ||
| Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. | Q54057043 | ||
| CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. | Q54139898 | ||
| CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers | Q56901953 | ||
| Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation | Q56904469 | ||
| Better survival rates in patients with MLH1-associated hereditary colorectal cancer | Q57567998 | ||
| Differential regulation of T-cell growth by IL-2 and IL-15 | Q59748325 | ||
| A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy | Q60709610 | ||
| Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer | Q61773591 | ||
| Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC). | Q64882755 | ||
| Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance | Q67297922 | ||
| Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course | Q68522182 | ||
| Characterization of activated lymphocytes in colon cancer | Q69735076 | ||
| Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history | Q72657539 | ||
| Dendritic cells prevent lymph node metastasis in patients with gastric cancer | Q72895165 | ||
| Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer | Q73038086 | ||
| TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis | Q73064321 | ||
| Hereditary colorectal cancer | Q73088287 | ||
| Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer | Q73345126 | ||
| IL-6 and IFN-gamma regulation of IL-10 production by human colon carcinoma cells | Q73442800 | ||
| Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer | Q73828602 | ||
| Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status | Q73887439 | ||
| Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma | Q74046178 | ||
| Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis | Q74352294 | ||
| CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma | Q75225386 | ||
| CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma | Q75310582 | ||
| Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma | Q77364836 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| CD3-zetachain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients | Q77839001 | ||
| Functional expression of beta1 and beta2 integrins on tumor infiltrating lymphocytes (TILs) in colorectal cancer | Q78085707 | ||
| Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma | Q78358411 | ||
| Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers | Q79157496 | ||
| Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer | Q79203534 | ||
| Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients | Q79351956 | ||
| Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic | Q79834699 | ||
| Beta2-microglobulin mutations in microsatellite unstable colorectal tumors | Q79992074 | ||
| CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer | Q81323711 | ||
| Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy | Q81586562 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 231-239 | |
| P577 | publication date | 2009-01-23 | |
| P1433 | published in | Familial Cancer | Q15761917 |
| P1476 | title | Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer | |
| P478 | volume | 8 |
| Q36228663 | A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer |
| Q35584153 | A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy |
| Q35560811 | Anticipation in lynch syndrome: where we are where we go |
| Q37144362 | Clinical implications of microsatellite instability in sporadic colon cancers |
| Q39668107 | Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study |
| Q21328691 | Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients |
| Q38670418 | Genomic and transcriptomic heterogeneity of colorectal tumors arising in Lynch Syndrome |
| Q37880662 | Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. |
| Q42951434 | Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors |
| Q34522172 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy |
| Q90609132 | Microsatellite instability in colorectal cancer |
| Q34755943 | Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value |
| Q30379025 | Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes. |
| Q91656747 | Possible Biomarkers for Cancer Immunotherapy |
| Q34683929 | Regulatory T lymphocytes are associated with less aggressive histologic features in microsatellite-unstable colorectal cancers. |
| Q35863187 | Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. |
| Q33632100 | T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth |
| Q89882588 | The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis |
| Q91520697 | The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy |
| Q103728292 | The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies |
| Q33552813 | Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients |
| Q55518010 | Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. |
| Q40757402 | Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer |
Search more.